Growth Hormone: What It Does, What Raises It, and Why Deficiency Is Frequently Misattributed

Growth hormone (GH) is a 191-amino-acid peptide secreted in pulsatile bursts by somatotroph cells in the anterior pituitary. Its name suggests it is primarily relevant to children and pharmaceutical athletes. The reality is more complex and more applicable to everyday physiology.

What Growth Hormone Actually Does in Adults

In adults, GH does not drive linear bone growth (the epiphyseal plates are closed). Its metabolic functions:

• Lipolysis: GH activates hormone-sensitive lipase in adipocytes, increasing free fatty acid release from fat stores — a direct fat mobilization effect. GH is strongly lipolytic.
• Protein synthesis: GH (primarily via IGF-1, which GH stimulates in the liver) promotes amino acid uptake into muscle and increases ribosomal protein synthesis rate.
• Anti-insulin effects: GH reduces peripheral insulin sensitivity — it competes with insulin at the insulin receptor level. This is why GH abuse in athletes produces insulin resistance. Physiological GH secretion at normal amplitudes does not produce clinically significant insulin resistance.
• IGF-1 induction: GH's primary systemic anabolic effect is largely mediated by hepatic IGF-1 production. IGF-1 is the downstream messenger for GH's growth-promoting and anti-atrophic effects on muscle.

> 📌 Vahl et al. (1997) in a controlled study of GH-deficient adults vs. matched controls found that adults with GH deficiency had reduced lean mass, increased fat mass (particularly visceral), reduced exercise capacity, and reduced quality of life scores compared to controls — establishing that GH is a metabolically significant adult hormone, not merely a pediatric growth factor. [1]

What Regulates Natural GH Secretion

GH is released in pulses, primarily at night during slow-wave (deep) sleep. The hypothalamus regulates GH release through two competing peptides:

• GHRH (growth hormone-releasing hormone): Stimulates GH release from pituitary somatotrophs
• Somatostatin: Inhibits GH release

The largest GH pulse of the day occurs during the first slow-wave sleep phase, approximately 1–2 hours after sleep onset.

What increases GH:

• Deep sleep (the primary physiological stimulus)
• Fasting and significant caloric restriction (via ghrelin's GH-releasing effect)
• High-intensity exercise, particularly anaerobic efforts
• Hypoglycemia
• Arginine administration (mild stimulatory effect via somatostatin inhibition)

What suppresses GH:

• Obesity and elevated body fat (visceral fat specifically produces somatostatin and impairs GH pulse amplitude)
• Elevated blood glucose and insulin (post-meal GH suppression)
• Disrupted or insufficient sleep
• Chronic stress (cortisol suppresses GHRH)

The Obesity-GH Deficiency Connection

Obese individuals often have biochemically low GH levels — reduced pulse amplitude and frequency — that look similar to clinical GH deficiency. This is not a pathological failure of pituitary function; it is the expected GH suppression from:

• 1. Elevated free fatty acids (which inhibit somatotroph GH release)
• 2. Increased somatostatin tone from visceral fat-derived factors
• 3. Hyperinsulinemia (post-meal insulin peaks suppress GH)

The consequence: obesity reduces GH, which reduces lipolysis and reduces lean mass maintenance, which worsens obesity — a self-perpetuating loop. Weight loss (fat reduction specifically) restores GH pulse amplitude without pharmaceutical intervention.

This is one reason why fat loss accelerates in the first stages of weight reduction: as visceral fat decreases, GH secretion partially restores, increasing the lipolytic contribution to fat loss.

---

Key Terms

• Pulsatile secretion — GH and many other pituitary hormones are not secreted continuously but in distinct bursts throughout the day; the largest and most metabolically significant GH pulses occur during slow-wave sleep
• IGF-1 (Insulin-like Growth Factor 1) — the primary downstream mediator of GH's anabolic effects; produced in the liver in response to GH; acts on muscle, bone, and multiple other tissues to promote protein synthesis and cell growth
• Somatostatin — the hypothalamic inhibitor of GH release; elevated in obesity through visceral fat-derived mechanisms; the primary factor reducing GH pulse amplitude in the obese state
• Lipolysis acceleration — the GH-mediated stimulation of hormone-sensitive lipase in adipocytes; the mechanism by which GH contributes to fat mobilization, distinguishing it from muscle-only anabolic hormones

---

Scientific Sources

• 1. Vahl, N., et al. (1997). Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology, 272(6 Pt 1), E1108–E1116. PubMed
• 2. Ho, K.K. (2007). Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II. European Journal of Endocrinology, 157(6), 695–700. PubMed